Healixa Inc. Announces Major Milestone Towards Commercialization of its Global AquaDuct® Product
Healixa, Inc. (OTC: EMOR) announced a significant achievement in its thermal deposition water harvesting technology, marking a milestone in its commercialization efforts. The company’s Global AquaDuct® technology can now produce potable water from the atmosphere, demonstrating improved performance in energy efficiency and yield reliability. Healixa has received over $75 million in order indications and plans to showcase its Minimum Viable Product (MVP) to government representatives and NGOs in early 2023. This advancement aims to address the global water scarcity crisis.
- Achieved a first-of-its-kind functional milestone for thermal deposition water harvesting.
- Global AquaDuct® technology demonstrates improved operational performance, including energy efficiency and reliability.
- Received over $75 million in order indications.
- None.
Healixa’s Team Has Achieved A First-of-Its-Kind Functional Thermal Deposition Water Harvester
New York, NY, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Healixa, Inc. (OTC: EMOR) ("Healixa," or the "Company"), a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water, and green-tech industries, today announced that as a result of successful pre-commercialization efforts, it has achieved a first-of-its-kind functional milestone for its thermal deposition water harvesting technology which is now capable of continuous water production. Healixa will also be providing commercialization updates and technology demonstrations to international government representatives, non-government organizations (NGOs) and other industry participants during an invite-only onsite tour of its development facility in South Carolina during the first quarter of 2023.
Global AquaDuct®, Healixa’s proprietary atmospheric water harvesting (“AWH”) technology, can produce potable water directly from the earth’s atmosphere by leveraging multiple advancements including a novel thermal deposition technology. Healixa’s AWH technology directly addresses challenges that have previously stifled adoption of atmospheric water solutions, specifically delivering substantially improved operational performance including energy efficiency, no relative humidity dependency, and substantial reliable yields. To date, Healixa has already received over
“Healixa has achieved the latest milestone in its multi-year R&D and commercialization program for its unique Global AquaDuct® AWH solution having exceeded all our internal development requirements and reaching the Minimum Viable Product (MVP) stage. As we quickly advance our commercialization efforts in 2023, we are especially excited to demonstrate Global AquaDuct® MVP to select end users,” commented Ian Parker, Chairman and CEO of Healixa. "On behalf of our management team, directors and advisory board, we wish to acknowledge the outstanding work and dedication of our engineering teams and manufacturing partners who supported us and look forward to doing our part to help address the growing global water scarcity crisis.”
About Healixa, Inc.
Healixa is a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water generation and green-tech industries. Healixa embraces innovation by combining its intellectual properties, patents, strategic collaborations, and partnerships to create a "LaunchPad" of disruptive sustainable products. For more information, visit www.healixa.com.
Safe Harbor Statement
Certain statements contained in this press release may constitute forward-looking statements. For example, forward-looking statements are used when discussing our expected research and development programs, and more. These forward-looking statements are based only on current expectations of management and are subject to significant risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including but not limited to the risks and uncertainties related to the progress, timing, cost, and results of Partnerships and product development programs; difficulties or delays in obtaining regulatory approval or patent protection; and competition from other companies. Except as otherwise required by law, Healixa, Inc. undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Healixia Contact:
Bret Hedges
SVP of Strategic Partnerships
833-432-5492
Bret@healixa.com
FAQ
What is Healixa's recent achievement regarding water harvesting technology?
What is the significance of the Global AquaDuct® technology from Healixa?
How much funding has Healixa received for its projects?
When will Healixa demonstrate its technology to potential partners?
